Tandem Diabetes Care, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tandem Diabetes Care, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $29.00K, a 83.04% decline year-over-year.
- Tandem Diabetes Care, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $711.00K, a 1.43% increase year-over-year.
- Tandem Diabetes Care, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $232.00K, a 45.67% decline year-over-year.
- Tandem Diabetes Care, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $46.00K, a 88.75% decline year-over-year.
- Tandem Diabetes Care, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $1.15M, a 48.54% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $2.23M, a 72.43% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $1.29M, a 85.82% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $9.13M, a 78.17% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-08-06 | $1.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $711.00K 10-Q · filed 2026-05-07 | $1.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.15M 10-K · filed 2026-02-19 |
| 2025-09-30 | $46.00K 10-Q · filed 2025-11-06 | $1.34M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $171.00K 10-Q · filed 2026-08-06 | $1.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $701.00K 10-Q · filed 2026-05-07 | $2.69M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.23M 10-K · filed 2026-02-19 |
| 2024-09-30 | $409.00K 10-Q · filed 2025-11-06 | $1.83M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.15M 10-Q · filed 2025-08-06 | $1.53M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $248.00K 10-Q · filed 2025-04-30 | $687.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.29M 10-K · filed 2026-02-19 |
| 2023-09-30 | $106.00K 10-Q · filed 2024-11-06 | $3.42M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $305.00K 10-Q · filed 2024-08-01 | $3.90M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $857.00K 10-Q · filed 2024-05-02 | $6.21M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $9.13M 10-K · filed 2025-02-26 |
| 2022-09-30 | $583.00K 10-Q · filed 2023-11-01 | $18.50M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $2.62M 10-Q · filed 2023-08-03 | $36.91M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $3.78M 10-Q · filed 2023-05-03 | $42.47M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $11.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $41.82M 10-K · filed 2024-02-21 |
| 2021-09-30 | $18.99M 10-Q · filed 2022-11-02 | $35.29M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $8.17M 10-Q · filed 2022-08-03 | $45.33M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $3.14M 10-Q · filed 2022-05-04 | $49.41M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $57.75M 10-K · filed 2023-02-22 |
| 2020-09-30 | $29.03M 10-Q · filed 2021-11-03 | $55.92M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $12.26M 10-Q · filed 2021-08-04 | $33.93M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $11.47M 10-Q · filed 2021-05-05 | $27.25M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $17.68M 10-K · filed 2022-02-22 |
| 2019-09-30 | $7.03M 10-Q · filed 2020-11-05 | $15.07M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $5.58M 10-Q · filed 2020-07-30 | $8.50M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.90M 10-Q · filed 2020-04-30 | $2.93M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $557.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.03M 10-K · filed 2021-02-24 |
| 2018-09-30 | $467.00K 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $7.00K 10-Q · filed 2019-08-01 | |
| 2017-12-31 | $270.00K 10-K · filed 2020-02-24 | |
| 2016-12-31 | $170.00K 10-K · filed 2019-02-26 | |
| 2015-12-31 | $337.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $325.00K 10-K · filed 2017-03-08 | |
| 2013-12-31 | $66.00K 10-K · filed 2016-02-24 | |
| 2012-12-31 | $35.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |